Skip to content

Effect of early mobilisation combined with additional protein on muscle mass in critically ill patients

Effect of early mobilisation combined with additional protein on muscle mass in critically ill patients - Protein delivery after early mobilisation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46556
Enrollment
40
Registered
2018-05-24
Start date
2018-07-07
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alle patienten opgenomen op de ICU voor tenminste 72 uur Critical illness muscle weakness

Interventions

Intervention group: Optimal feeding (proteins 1.5 g/kg), early mobilization (3 times a day), directly after mobilisation additional 15 grams of proteins. Control group: Optimal feeding (proteins 1.5

Sponsors

Medisch Spectrum Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Expected to stay on the ICU for at least 72 hours. - Complete enteral nutrition. Or enteral nutrition in combination with parenteral or oral nutrition.

Exclusion criteria

Exclusion criteria: - Complete parenteral feeding - Chronic renal failure or hepatic encephalopathy - Acute kidney injury without CVVH or IHD - Poor prognosis - Progressive neuro-muscular disease or neurotrauma as reason for ICU admission

Design outcomes

Primary

MeasureTime frame
The main study parameter is the percent change in muscle thickness of the mid-upper arm, forearm and thigh measured by ultrasonography, from baseline to ICU admission.

Secondary

MeasureTime frame
Secundary study parameters are: * Muscle quality of the rectus femoris and vastus intermedius muscles separately (echogenicity) measured by ultrasonography. * Muscle force measured by MRC sum score and handgrip force * Functional status (DEMMI) * Nutritional state and hydration status with the bivameter. * Quality of life (EQ-5D)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)